Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Rifampin - Generic Drug Details

« Back to Dashboard

What are the generic sources for rifampin and what is the scope of rifampin freedom to operate?

Rifampin
is the generic ingredient in three branded drugs marketed by Emcure Pharms Ltd, Akorn, Sanofi Aventis Us, West-ward Pharms Int, Mylan Labs Ltd, Oxford Pharms, Lupin Pharms, Watson Pharms Teva, Hikma Pharms, Sandoz, Fresenius Kabi Usa, and Lannett, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for rifampin. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: rifampin

Tradenames:3
Patents:1
Applicants:12
NDAs:15
Drug Master File Entries: see list9
Suppliers / Packagers: see list28
Bulk Api Vendors: see list59
Clinical Trials: see list74
Patent Applications: see list8,381
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rifampin at DailyMed

Pharmacology for Ingredient: rifampin

Ingredient-typeRifamycins
Drug ClassRifamycin Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett
RIFAMPIN
rifampin
CAPSULE;ORAL065390-002Mar 28, 2008ABRXNoNo► Subscribe► Subscribe
Akorn
RIFAMPIN
rifampin
CAPSULE;ORAL065028-001Mar 14, 2001ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
RIFAMPIN
rifampin
INJECTABLE;INJECTION064217-001Oct 29, 1999APRXNoNo► Subscribe► Subscribe
Sandoz
RIFAMPIN
rifampin
CAPSULE;ORAL064150-002Jan 2, 1998ABRXNoNo► Subscribe► Subscribe
Sanofi Aventis Us
RIFADIN
rifampin
INJECTABLE;INJECTION050627-001May 25, 1989APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot